Portuguese consumers are expected to switch from ingredients they see as less efficient to those which are reputed to act faster. Therefore, the strong performance of ibuprofen and diclofenac is expected to offset the weaker development of aspirin. Consumers’ inclination towards self-medication and the increasing incidence of headaches and other pain due to stress brought on by hectic lifestyles are expected to be the two main factors behind the future sales of ibuprofen and diclofenac. These pr...
Euromonitor International's Analgesics in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Get a detailed picture of the Analgesics market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market’s major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.